OpenResearchAlpha

Current Opinion in Nephrology & Hypertension · 6 Nov 2026

Artificial intelligence in dialysis

Len A. Usvyat

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
12
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Purpose of review Artificial intelligence (AI) and machine learning in dialysis have matured beyond the initial phase of algorithm development. Recent work has shifted toward clinical implementation, evaluation, and governance. During the past year, the first randomized trial of AI-guided dosing in maintenance hemodialysis has been published, a meta-analysis of technology-guided dry-weight adjustment has appeared, and the first professional society framework for the responsible use of AI in kidney care has been released. Recent findings The Anemia Control Model is now supported by hospitalization outcomes and cost-effectiveness analyses. A randomized trial demonstrated that AI-guided erythropoiesis-stimulating agent dosing achieved outcomes comparable to physician-directed dosing. Technology-guided dry-weight adjustment is supported by a meta-analysis of 21 randomized trials. Machine learning for vascular access is evolving toward preoperative clinical decision support, while peritoneal dialysis is beginning to receive greater attention from the machine learning community. Large language models are entering nephrology along two complementary paths: open generative systems for education and clinical support, and deterministic, protocol-driven frameworks designed for safety-critical bedside applications. At the same time, the U.S. Food and Drug Administration has released comprehensive lifecycle guidance for AI-enabled medical devices. Summary The major challenge for AI in dialysis is no longer developing accurate prediction models. Instead, success will depend on effective workflow integration, validation across diverse patient populations, ongoing postdeployment monitoring, and demonstrating meaningful improvements in patient outcomes.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (1)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (12)

What it cites, from open citation data, with Crossref's record of each.